ClinicalTrials.Veeva

Menu

Machine Learning Assisted Electrochemical Profiling to Provide Early Identification of Bloodstream Infections Pathogens (E-MOC)

Grenoble Alpes University Hospital Center (CHU) logo

Grenoble Alpes University Hospital Center (CHU)

Status

Not yet enrolling

Conditions

Bacteremia Sepsis

Treatments

Other: Blood culture sampling

Study type

Interventional

Funder types

Other

Identifiers

NCT06853301
2024-A02517-40 (Other Identifier)
38RC24.0111_EMOC

Details and patient eligibility

About

In the context of a bacteremia, although significant progress has been made in speeding up pathogen identification once a blood culture bottle turns positive, few cost-effective solutions have been proposed to improve the earlier stages of the process-specifically, from blood collection to bottle positivity. The investigators propose that transport time could be leveraged to grow and identify bacteria, enabling faster access to actionable results through innovative technologies. This project aims to develop a bacterial identification database by analyzing the electrochemical profile of bacteria growing within the blood culture bottle, using machine learning.

Enrollment

200 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • patient requiring a blood culture sample as standard of care procedure
  • body weight > 50 Kg
  • Patient for whom the collection of 2 to 4 additional blood culture bottles is feasible, depending on venous access
  • patient who has not objected to participation in the project

Exclusion criteria

  • Patient protected under the French Public Health Code (pregnant or breastfeeding women, patients under guardianship or curatorship, hospitalized under constraint, or deprived of liberty)
  • patients with ongoing antibiotic treatment at the time of sampling

Trial design

Primary purpose

Diagnostic

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

200 participants in 1 patient group

Patients
Experimental group
Description:
Patients with blood culture sampling as standard of care. Two to four additional blood culture bottles sampled
Treatment:
Other: Blood culture sampling

Trial contacts and locations

2

Loading...

Central trial contact

Yvan CASPAR, PharmD, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems